Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Nanopart Res. 2014 Oct 11;16(11):2662. doi: 10.1007/s11051-014-2662-1

Fig. 4.

Fig. 4

Tumor RDI-OT versus time curves following the administration of CMAs and SMs. The tumor RDI-OT versus time curves for all agents included in the study. Tumor RDI-OT is defined as the concentration of drug in tumor divided by the concentration of drug in plasma at each time point. Curves with corresponding symbols indicate that those agents are from the same study. Blue curves represent SMs, green curves represent non-liposomal nanoparticles, black curves represent PEGylated lipsomes, orange curves represent non-PEGylated liposomes, and red curves represent conjugated agents. (Color figure online)